Terry’s cancer journey: Triumphant testimony to the power of precision oncology

By Gwyn Bebb, M.D., BM, BCh, Ph.D., Senior Vice President, Global Therapeutic Area Head – Oncology

For over 20 years, precision oncology has advanced cancer care by tailoring treatments to individual needs, improving outcomes, and empowering patients on their cancer journey. Bev Hope, Marketing Strategy Director interviews Dr. Gwyn Bebb, Senior Vice President and Global Therapeutic Head of Oncology, and his former patient Terry Morey, a stage four non-small cell lung cancer survivor. They share their unique journey battling Terry’s NSCLC through the lens of precision oncology. Terry’s experience with various treatments, including ALK inhibitors, sheds light on the transformative potential of precision oncology for more cancer patients. 

Their story highlights the importance of expanding patient access to clinical trials and biomarker testing. It is a story about science, the human spirit, resilience, and relentless pursuit to transform lives. Terry’s cancer journey is a beacon of hope and a testament to the power of precision oncology to revolutionize cancer care and improve outcomes for more cancer patients and their families today and in future generations.

Contributing Experts